Recombinant Anti-CD37 x Anti-saporin Bispecific Antibody (IgG-Fv) (BSGV-118)

Recombinant Anti-CD37 x Anti-saporin Bispecific Antibody (IgG-Fv) is formed by an Immunoglobulin G (IgG) and a fragment variable Fv region, in which the Fc of IgG is engineered by KIH. The Fv region of an anti-CD37 antibody variable domain is fused to the C terminal of an IgG of anti-saporin antibody, or vice versa. The format retains desired characteristics of intact antibodies. This BsAb can be used in pretargeting system and deliver immunotoxin to tumor cells. It is designed for the research of Non-Hodgkin's lymphoma (NHL); Diffuse large B cell lymphoma (DLBCL); Chronic lymphocytic leukemia (CLL) therapy.

Datasheet INQUIRY

Specifications

Targets

CD37 & saporin

Type

IgG-Fv

Species Reactivity

Human

Application

FuncS; Pretargeting system for immunotoxin delivery

Related Disease

Non-Hodgkin's lymphoma (NHL); Diffuse large B cell lymphoma (DLBCL); Chronic lymphocytic leukemia (CLL)

Targets

Target 1

CD37

Gene ID

951

UniProt ID

P11049

Alternative Names

CD37; CD37 molecule; GP52-40; TSPAN26; leukocyte antigen CD37; tspan-26; tetraspanin-26; leukocyte surface antigen CD37; cell differentiation antigen 37

Target 2

saporin

Alternative Names

Saporin; Ribosome inactivating protein; RIP

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-CD37 x Anti-saporin Bispecific Antibody (IgG-Fv) (BSGV-118). Click the button below to contact us or submit your feedback about this product.

Recombinant Anti-CD37 x Anti-saporin Bispecific Antibody (IgG-Fv) (CAT#: BSGV-118)

Specifications

Targets

Customer Reviews and Q&As